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ABSTRACT 
Objective: To study betulin-3,28-diphosphate (BDP) water solubility improved by forming salt complexes with hydrophilic amino alcohols: 
meglumine as acidosis corrector and xymedon as the water-soluble antioxidant. 
Methods: We used 13C-, 31P-NMR, UV-spectroscopy and potentiometric titration to study the BDP-amine salt complexes formation and their 
solubility using HPLC-analysis. 
Results: The participation of xymedon in the proton transfer reaction with BDP in aqueous solutions was confirmed by the bathochromic shift of 
the carbonyl band from 299.1 nm to 304.2 nm, and by a hyperchromic effect (molar extinction ε from 8508 to 10 441 l·mol-1·cm-1) in UV-spectra. 
BDP complexation with meglumine was estimated by UV-spectral molar ratio method at 256 nm. Molar ratio of BDP-amine complexes (1:4) was 
proved by 31P-NMR. The chemical shift of phosphorus at C-3 atom of BDP (δ =-0.58 ppm) changed to+3.39 ppm, and at C-28 atom (δ =+0.28 ppm)–
to+4.60 ppm. BDP solubility increased 100-600 fold according to HPLC-analysis. 
Conclusion: BDP interaction with amine in an aqueous solution was shown to proceed via a proton transfer due to relatively weak forces such as 
London forces, hydrogen bonding, electrostatic and hydrophobic interactions. In general, the formation of BDP salt complexes with amines in 
solution determines BDP water solubility. Water-soluble BDP enables to develop hydrophilic dosage forms. 
Keywords: Poorly water-soluble, Salt complex engineering, Betulin-3,28-diphosphate, Meglumine, Xymedon 




Lupane triterpenoids such as betulin (lup-20(29)-ene-3,28-diol) and 
its derivatives extracted from renewable natural resources [1-3], e. g. 
from birch bark, exhibit various types of pharmacological activity. The 
antioxidant, anti-inflammatory, hepatoprotective, antimutagenic, and 
other activities of the compounds were demonstrated by in vitro and 
in vivo experiments [4-9]. Recent studies have shown that betulin can 
be a useful structural scaffold in drugs to prevent and treat osteoclast-
mediated bone diseases [8]. 
The major problem to develop a dosage form, for most types of 
triterpenes, including betulin derivatives, is their low water-solubility 
[10]. The methods to increase the triterpenoids solubility are the 
formation of multiarm-polyethylene glycol–betulinic acid prodrugs 
[11], betulin diacetate complexes with polysaccharides [12], esters of 
betulin and betulinic acid with amino acids [13], salt of betulinic acid 
derivatives with organic cations (didecyldimethylammonium, choline 
and benzalkonium), alkali metals, etc. [14, 15]. The suitable techniques 
to modify and graft additional polar groups are the formation of 
sulfates, phosphonate and phosphate groups [16-22]. Moreover, the 
phospholipid derivatives of betulin with improved solubility were 
synthesized [17]. The betulin sulphates have been demonstrated to be 
selective potent inhibitors of C1q interaction of with immunoglobulins 
and the classical pathway of complement activation [16]. The most 
favorable modification is the grafting of phosphate derivatives by 3- or 
28-OH groups of betulin resulting in solubility improvement in 
comparison with the extremely low solubility of natural betulin (about 
1.0∙10-4-1.9·10-3 g·l-1 depending on conditions) [17-22]. 
Fig. 1a shows betulin-3,28-diphosphate (BDP) obtained by betulin 
phosphorylation with phosphorus oxychloride, BDP solubility in 
water is 50-1000 times higher than that of betulin, and its sodium 
salt (Na-BDP) solubility in water is up to 10 g·l-1 [18]. 
 
Fig. 1: Formulas of salt complexes components 
 
In addition to improved solubility, betulin phosphates and 
phosphonates showed high activity as potential drugs [18-23]. In vitro 
and in vivo experiments demonstrated antimicrobial [19], antifungal 
[20], anti-inflammatory, antiviral [21] activities and an antitumor 
effect in the treatment of ductal carcinoma, glioblastoma, melanoma 
[22], Ehrlich ascites carcinoma [23] and other diseases. 
However, the problem of using both betulin-3, 28-diphosphate and 
its sodium salts as an active pharmaceutical ingredient is the 
solubility reduction of these substances in storage. The aging of 
samples leads to the formation of a different structural modification 
characterized by more close packing of solid layers. The 
crystallization water of the hydrate Na-BDP ∙ 8H2O was removed 
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from molecules with time [18]. In this regard, it is very important to 
find methods to increase and stabilize BDP solubility. The findings 
may be useful to design new dosage forms including injectable 
preparations and hydrophilic gels. 
Meglumine ((2R,3R,4R,5S)-6-(methylamino)hexan-1,2,3,4,5-pentol, 
Megl) traditionally used both for acidosis correction, pH-regulation 
and making plasma isoosmotic and to improve permeability of 
poorly soluble lipophilic pharmaceutical substances [24, 25] was 
chosen as one of these amino alcohols (fig. 1b). 
A readily soluble drug having an amino alcohol group, e. g., a 
pharmaceutical active ingredient–xymedon (fig. 1c), also can be used 
as a component of a salt complex with BDP. In this case, the BDP 
molecule exhibiting weak acid properties can act as a component of 
a drug delivery vector for the group of amines with weak basic 
properties. Xymedon (1-(β-hydroxyethyl)-4,6-dimethyl-1,2-dihydro-
2-hydroxy-pyrimidine, Xym) is a heterocyclic amino alcohol having 
high antioxidant, reparative, anti-inflammatory and other activities 
[26]. The abnormal water solubility of xymedon (about 400 g∙l-1) and 
high pharmacological properties suggest that a complex of xymedon 
with betulin-3,28-diphosphate can be a novel antioxidant drug with 
an optimal BDP dose. 
In this paper, we studied the possibility of improving BDP water 
solubility by forming BDP water-soluble salt complexes with 
hydrophilic amino alcohols in solution. 
MATERIALS AND METHODS 
Materials 
Betulin was isolated from birch bark (Betula Pendula) using the 
methods [27]. The materials were meglumine (Merck, TD 
13015143333), xymedon (Sigma Aldrich, Moscow, Russia), lithium 
perchlorate (Sigma Aldrich, Moscow, Russia), phytic acid solution 50 
% (w/w) in H2O (Sigma Aldrich, Moscow, Russia), purified water 
(resistivity ≥18 MΩ∙cm, Millipore, Merck, Darmstadt, Germany). 
FTIR analysis 
FTIR spectra in 400–4000 cm−1 range were measured by an IR 
Prestige-21 FTIR spectrometer (Shimadzu, Kyoto, Japan) equipped 
with a KBr beam splitter. To perform the measurements, a pellet 
from a well-dried KBr was prepared according to standard cold 
pressing. Resolution was 0.5 cm−1. The number of scans was 45. 
UV analysis 
UV-spectra were recorded by UV-1800 (Shimadzu, Kyoto, Japan). 
RP-HPLC analysis 
RP-HPLC-analysis was carried out on LC-20Avp (Shimadzu, Kyoto, 
Japan) with UV-detection, the column is Discovery C18 (25 cm x 4.6 
mm, 5 μm, Supelco), retention time τ equals to 5.19 min. 
NMR analysis 
13С-, 1H-, 31Р-NMR spectra were recorded at 101, 400 and 202,46 
MHz, respectively, on a JNM-ECX400 NMR-spectrometer (Jeol Ltd., 
Tokyo, Japan), DMSO-d6 and D2O being used as solvents. 
Solubility determination 
Solubility was measured by shake-flask method [28]. An excess 
amount of BDP was added to the buffer solution (pH 6.8) by 
magnetic stirring during 24 h at 20 °C. The added BDP amount was 
enough to make a saturated solution in equilibrium with solid phase. 
After phase separation of saturated solution by filtration a liquid 
phase was analysed by RP-HPLC in isocratic modes (210 nm, 40 °C, 
mobile phase A30%-B70% v/v, A—acetonitrile, grade 0, B—buffer 
solution of KH2PO4, pH = 6.36; sample volume is equal to 20 μL, flow 
1.0 ml∙min−1. The retention time is 5.19 min.). 
Synthesis of betulin-3, 28-diphosphate and its sodium salt 
Betulin-3, 28-diphosphate (BDP, 3β, 28-diphosphate-lup-20(29)-ene) 
and its sodium salt were synthesized according to the procedure [18]. 
13C-31P and 1H-NMR spectra and physicochemical constants were in 
accordance with literature data [18]. BDP and its sodium salt assay 
were performed by reversed phase HPLC analysis: 210 nm, 40 °C, 
mobile phase A30%-B70% v/v (A—acetonitrile (grade 0), B—buffer 
solution of KH2PO4, pH = 6.36), flow 1.0 ml∙min−1. The retention time of 
BDP and its sodium salt was 5.19 min and 4.51 min, correspondingly. 
Biological activity in vitro 
Biological activity in vitro was studied using blood stabilized with 
sodium citrate (1:9). 
Catalase activity (EC 1.11.1.6) was determined by 
spectrophotometry based on hydrogen peroxide decomposition by 
the catalase [29]. Glutathione reductase activity (EC 1.8.1.7) was 
studied spectrophotometrically based on oxidized glutathione 
reduction [30]. The activity of glucose-6-phosphate dehydrogenase 
(EC 1.1.1.49) was determined in hemolysate of erythrocytes using 
spectrophotometry based on glucose-6-phosphate oxidation to the 
phosphoglucolactone with the formation of reduced nicotinamide 
adenine dinucleotide phosphate (NADPH) [31]. 
The study as presented was approved by the Local Ethics Committee 
of Privolzhsky Research Medical University, Russian Federation 
(Protocol No.2-20.02.16 dated 20 February 2016). 
RESULTS 
Acid-base interactions of betulin-3, 28-diphosphate with 
aqueous solutions of amines (xymedon and meglumine) 
The pH decreased from the initial values pH 0Megl and pH 0Xym to pH 
3.75 in the potentiometric titration of 5.9∙10-5M xymedon (Xym) and 
meglumine (Megl) aqueous solutions by 2.9∙10-3M BDP ethanol 
solution (fig. 2).  
 
 
Fig. 2: The pH dependence on molar fraction α, pH = f (αBDP); α = 
nBDP/namine. The titration of 5.9∙10-5 M amine aqueous solution 
by 2.9∙10-3 M BDP ethanol solution: 1–meglumine; 2–xymedon. 
The inset shows pH = f(VBDP) after adding 2.9∙10-3 M BDP 
ethanol solution to water in a blank experiment. The initial 
amine solution volume was 100 ml 
 
The pH=f(αBDP) curves, where molar fraction α = nBDP/namine, leveled 
off at the molar ratio BDP: amine equal to 4:1 in pH 3.75, which is 
close to pH of BDP aqueous solution at the same concentration 
without amine (fig. 2, insert). The results are typical for a weak base 
titrated by a weak acid, although xymedon is a weak base and 
meglumine is medium-strength base [24, 25].  
According to the dependence of microspecies distributions (%) on 
pH (fig. 3) calculated using Chemicalize program, the main BDP ionic 
form at pH 3.75 corresponds to two-charged ion and minor BDP 
ionic form is a single-charged ion. 
Melnikova et al. 
Int J Pharm Pharm Sci, Vol 11, Issue 5, 48-55 
 
50 
The interaction between BDP and amines can be characterized as 
one-stage proton transfer reactions from each BDP phosphate 
group. 
The study of proton transfer reaction of BDP with xymedon 
The acid-base interaction of BDP with amines was studied by UV-
and 31P-NMR spectra. BDP phosphate groups have absorption in the 
range of 240-270 nm [32]. The carbonyl chromophore band (n-π* 
and π-π* transitions) of xymedon was characterized by intense 
absorption in the region of 299 nm, while the amino alcohol 
meglumine does not appear in this UV spectrum region. Therefore, it 
is possible to study BDP interaction with xymedon using a 299-nm 
band, while the interaction with meglumine can be controlled by 
phosphate group absorption only. 
 
 
Fig. 3: The dependence of BDP microspecies distributions (%) on pH calculated using Chemicalize program 
 
The fully protonated xymedon form was characterized using 
xymedon hydrochloride salt as a control sample synthesized from 
ethylurea and acetylacetone in the presence of hydrochloric acid 
[20]. UV-spectrum of xymedon hydrochloride shows the absorption 
band with wavelength λmax = 308.8 nm in contrast to λmax = 299.0 nm 
for xymedon. 
We studied the interaction of BDP with xymedon in aqueous 
solution in the conditions corresponded to potentiometric titration 
when xymedon concentration was the same (5.9·10-5 M), and the 
ionic strength in the system was provided by 5.9·10-4 M lithium 
perchlorate. 
The participation of xymedon in the proton transfer reaction with 
BDP in aqueous solutions was confirmed by bathochromic shift of 
the carbonyl chromophore band from 299.1 nm to 304.2 nm, and a 
hyperchromic effect manifested in an increased molar absorption 
coefficient ε from 8508 to 10 441 l·mol-1·cm-1 (fig. 4a, table 1). 
 
 
Fig. 4: UV absorption spectra of 5.9·10-5M aqueous solution of xymedon and its protonated form obtained: a) in mixture with BDP; CLiClO4 = 
5.9·10-4 M; b) in acetate-phosphate-borate buffer solution and in phytic acid (thick dashed line) 
 
Spectra of xymedon and BDP mixtures were compared with those of 
xymedon salts obtained in aqueous acid solutions. The conditional 
molar extinction coefficient ε of xymedon hydrochloride (standard 
sample) was equal to 10 788 l·mol-1·cm-1, and the absorption band at 
λmax equal to 309 nm practically coincided with the spectral 
characteristics of xymedon at the same concentration in 0.1 M 
hydrochloric acid solution.  
We compared “xymedon-BDP” with “xymedon-phytic acid” aqueous 
systems to estimate the role of phosphate groups in the interaction. 
Acid-base properties of organic phosphates–phosphoric acid 
metabolic derivatives, such as various phosphorylated inositols–InsPx 
(x = 1-6) and phytic acid InsP6, glucose phosphates, glycerol phosphates, 
are similar to BDP. The ionization of phosphate groups of inositol and 
proton transfer reaction proceeds like the processes in aqueous 
phosphoric acid solution. The pKa values of the separation of the first 
and second protons of these compounds, as well as for phosphoric 
acid, are 1.5±0.5 and 6.7±0.5, respectively [33]. Moreover, phytic acid 
forms different kinds of complexes with amines due to not only proton 
transfer, but also non-specific covalent binding [34]. 
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Table 1: The UV spectral data of 5.9∙10-5M xymedon solutions in various aqueous media (betulin-3,28-diphosphate BDP or buffer 
solution) 
№ Conditions UV spectral data 
α = nBDP/nXym pH λ, nm A ε′, L·mol-1·cm-1 
1 0 5.76 299.1 0.502 8508 
2 0.5 4.75 299.8 0.505 8559 
3 1.0 4.10 300.7 0.516 8746 
4 1.5 4.02 301.6 0.539 9136 
5 2.0 3.96 302.5 0.549 9305 
6 2.5 3.92 302.9 0.558 9458 
7 3.0 3.88 303.5 0.575 9746 
8 3.5 3.82 303.6 0.578 9797 
9 4.0 3.79 303.9 0.583 9881 
10 4.5 3.75 304.1 0.605 10254 
11 5.0 3.72 304.2 0.616 10441 
 Acetate-phosphate- 
borate buffer 
12.86 299.7 0.467 7908 
 11.86 299.7 0.458 7759 
 11.24 299.8 0.458 7754 
 10.67 299.8 0.457 7733 
 6.00 299.9 0.453 7685 
1' 3.99 302.8 0.452 7667 
2' 3.72 305.3 0.513 8686 
3' 3.40 307.0 0.554 9391 
4' 3.22 307.6 0.577 9777 
5' 2.92 308.1 0.600 10 173 
6' 2.62 308.5 0.611 10 357 
7' 2.31 308.7 0.618 10 469 
8' 1.33 308.8 0.637 10 788 
9' Phytic acid1 – 308.7 0.637 10 575 
1CPA = 1.0·10-5M, molar ratio of PA: Xym = 1:6. α = nPA/nXym = 0.17 
 
Previously we showed that BDP like phytic acid forms salt complexes 
with amines [35] by proton transfer reaction like phosphoric acid. 
The spectrum of xymedon in phytic acid solution with a molar ratio 
of phytic acid: xymedon = 1: 6 was the same as xymedon 
hydrochloride spectrum (fig. 4b, table 1). It is significant that a 
conditional molar extinction coefficient ε was close to 10 600±200 
l·mol-1·cm-1 in all acid solutions under study at various pH values 
(table 1) and it was different from xymedon in water. 
The results can probably be explained by the formation of xymedon 
and BDP complexes, when xymedon is not fully protonated, in 
contrast to xymedon salts formed by strong acids.  
The significant increase of ε when pH decreases from pH 6.00 to pH 
3.75 (corresponding to the plateau on pH = f(α) curve, fig. 2), and 
practically linear symbatic dependence of ε on BDP molar fraction α 
in the same pH region (fig. 5 a,b) prove the proton transfer between 
BDP and Xym. 
 
 
Fig. 5: a) The solution pH as a function of the molar extinction coefficient ε, pH = f (ε); b) Dependence of the extinction coefficient ε on αBDP, 
ε = f(αBDP) 
 
13C-and 31P-NMR spectral data of BDP-Xym mixture in D2O show the 
significant changes of spectra compared to the spectra of individual 
BDP and Xym (table 2, fig. 6). 13C-NMR spectra of xymedon 
hydrochloride and xymedon phytate were studied as well. Strong 
changes of chemical shifts of carbonyl carbon signals from 175 ppm 
to 146-149 ppm were observed in the spectra of all compounds 
under study (table 2). The signals of carbons designated C-4 and C-6 
also changed. 
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Fig. 6: 31P-NMR spectra of BDP (top) in DMSO-d6 and BDP-Xym mixture (bottom) in D2O. PPh3 is a standard 
 











Group -СН3 (at C-6) -СН3 (at C-4) N-CH2 (1) -CH2-OH HC= 
(C-5) 
C=N (C-4) C=  
(C-6) 
C=O (C-2) 
13C-NMR, δ, ppm 
Xym 20.1 23.1 47.9 58.4 108.3 160.6 157.9 175.5 
Xym-chloride 19.4 21.7 49.4 57.8 108.3 172.1 168.5 149.0 
Xym-phytate 19.5 23.6 49.4 57.8 108.2 171.9 168.4 148.9 
Xym-BDP 18.0 21.3 48.8 57.6 106.5 169.7 166.8 146.4 
 
The chemical shift δ of phosphorus at C-3 atom of the pure BDP 
is equal to -0.58 ppm (doublet without decoupling from protons) 
and δ of phosphorus at C-28 is equal to +0.28 ppm. The chemical 
shifts of phosphorus atoms changed in BDP-Xym mixture 
spectrum (1:4) to+3.11 ppm at C-3 and to+4.44 ppm at C-28. 
Two non-intensive and unresolved signals (close to the main 
signals, δ1 = 2.7 ppm, δ2 = 4.0 ppm) may describe the product of 
xymedon interaction with only one hydroxyl of BDP phosphate 
group. 
Thus, taking into consideration the potentiometric titration data, UV and 
NMR spectra of reaction mixtures of BDP with xymedon, it is arguable 
that the interaction of BDP with xymedon proceeds with the formation of 
salt complexes and via a proton transfer reaction in the solution. 
 
 
Fig. 7: The UV spectra in 5.1·10-4M solutions of BDP in the presence of meglumine, CLiClO4 = 1·10-2 M: a) A = f(λ); b) the dependence of A256 
absorption on the molar ratio of meglumine to BDP, A = f (αMegl) in fresh solutions (1) and after 4 d (2), α = nMegl/nBDP 
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The acid-base interaction of BDP with meglumine 
In the aqueous medium BDP UV-spectra were characterized by a 
band of the phosphate group (n→p*, p→p* transitions) at λmax = 256 
nm. BDP phosphate groups under ionization can be considered as an 
amphoteric ion (B on fig. 3) both as an acid and a base conjugated to 
the acid. The molar extinction coefficient ε of initial BDP in ethanol 
solution (curve 1 at fig. 7a) is almost twice as much than ε of BDP in 
NaOH aqueous solution that characterizes the ionized form, 
represented by base D presented in fig. 3. Therefore, absorption A 
values at 265 nm and, correspondingly, conditional molar extinction 
coefficient ε can characterize BDP ionization and its interaction with 
Megl, which has no band in this region. 
Fig. 7a shows the spectra of 5.0·10-4M BDP and meglumine (Megl) 
mixtures at molar ratio α (α = nMegl/nBDP) from 0 to 5, when BDP 
concentration was 5.0·10-4M and an ionic strength was supported by 
1∙10-2M LiClO4. Fig. 7 and table 3 data show A256 decrease while the 
molar ratio α increases. 
It should be noted that the absorption of BDP phosphate groups 
changed with time during 4 d in aqueous solution without 
meglumine. Fig. 6b (1 and 2 curves) shows the molar extinction 
coefficient ε and the absorption increase approximately half as 
much. It may be explained by the increase with time of the BDP ionic 
A fraction having higher ε values than ε values of ionic B form in 
initial BDP solution. 
After adding meglumine at essential meglumine excess (α≥2), 
absorbance (A) and ε values were the same and did not practically 
depend on α. The “plateau” both on the curve A = f(α) (fig. 7b) and on 
the curve pH = f(α) (fig. 2) appears in α≥2 region and reflects the same 
BDP ionization in BDP-Megl mixture under the studied conditions. 
It is possible that such BDP ionization has the nature of the salt 
complex formation similar to BDP salt complexation with trisamine 
[35]. The composition of the BDP-trisamine complex was proved 
using Job’s method, and the conditional stability constant equal to 
1130 mol∙l-1 was calculated [35]. 
 
Table 3: UV-spectra data according to fig. 8 a,b 
№  
curve 




A ε, l∙mol-1∙cm-1 
A0 A, τ = 4 d ε0 ε, τ = 4 d 
1 0.00 0.00 0.437 0.709 874 1418 
2 0.50 2.50 0.435 0.580 870 1160 
3 0.75 3.75 0.384 0.546 768 1092 
4 1.00 5.00 0.376 0.401 752 802 
5 1.50 7.50 0.273 0.333 546 666 
6 1.75 8.75 0.262 0.327 524 654 
7 2.00 10.00 0.251 0.263 502 526 
8 3.00 15.00 0.268 0.295 536 590 
9 4.00 20.00 0.258 0.263 516 526 
10 5.00 25.00 0.258 0.236 516 472 
Note: ε of BDP solutions (l∙mol-1∙cm-1): in 0.02M ethanol H2SO4 solution is 663; in 4∙10-3M aqueous NaOH solution is 418; in 95% ethanol–water (1:1) 
medium with LiClO4 is 761. 
 
 
Fig. 8: 31P-NMR spectra of BDP-Megl complexes in D2O. H3PO4 is standard 
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The interaction of BDP with meglumine in a solution was also 
studied using 31P-NMR spectra (fig. 8). The chemical shift of 
phosphorus at C-3 atom of BDP (δ =-0.58 ppm) changed to+0.88 
ppm, and at C-28 atom (δ =+0.28 ppm)–to+2.46 ppm in case of BDP-
meglumine mixture (1:2). The chemical shifts depended on the BDP: 
meglumine ratio, and signals appeared in the weaker field with 
δ=+3.39 ppm (at C-3) and δ=+4.60 (C-28) at molar BDP: meglumine 
ratio equal to 1:4 (fig. 8), similar to phosphorus signals of BDP-
xymedon salt complexes (fig. 6). The molar ratio of BDP: meglumine 
more than 1:4 did not change chemical shifts. 
BDP solubility and antioxidant activity of BDP salt complexes 
with amines 
The argument for strong intermolecular interactions of BDP with 
Megl, probably resulting in salt complexes formation in solution, is a 
sharp increase of BDP solubility in aqueous meglumine solutions 
(table 4). HPLC analysis showed that BDP solubility in water (0.1 g·l-1) 
significantly increased in the presence of meglumine, and the 
solubility of complex compounds did not depend on the initial 
BDP aging in storage (the transformation to BDP structural 
modification with lower solubility). The maximum BDP solubility 
in water (59 g·l-1 at 20 °C) was achieved in the presence of 
meglumine at a molar ratio of components 1:4, BDP solubility being 
nearly 6 times greater than its solubility in the form of sodium salts. 
We studied the precipitates obtained by freeze-drying of BDP 
solutions with amines (at molar ratios of 1:1, 1:2, 1:4 and 1:6) as 
well. The 31P, 13C-NMR and UV spectral data of aqueous solutions 
(D2O) of precipitates and initial components of model mixtures at 
same molar ratios were identical. The data suggest BDP dissolution 
in the meglumine medium to be largely due to hydrogen bonds, 
proton transfer interactions, and, ultimately, the interaction 
between the cationic and anionic parts of the complex components. 
 
Table 4: Water solubility of BDP and its products at 20 °C according to HPLC-analysis 
Compound CBDP, g·l-1 
BDP a 0.15 
BDP b 0.09 
Na-BDP a 10.00 
Na-BDP b 4.00 
BDP: Xym (molar ratio is 1:4) 0.30 
BDP a: Megl (molar ratio is 1:4) 59.00 
BDP b: Megl (molar ratio is 1:4) 35.00 
afresh prepared, bafter storage during 3 mo. 
 
The higher water-solubility of amorphous BDP-Megl salt 
complexes than crystalline Na-BDP can be explained by the 
stronger decrease of hydrophobic bonding between BDP dimer 
molecules by Megl due to hydrogen bonds. The effective 
antioxidant-regenerant xymedon, which has a high ability both to 
hydrogen bonding and to form stacking structures like pyrimidine, 
cannot significantly weaken the hydrophobic binding in the BDP 
dimer and, accordingly, improve its solubility. The poor water-
soluble salt complex of xymedon with BDP is of interest as a 
dosage form of xymedon with an optimal dose, in contrast to its 
known dosage forms with very high dose (1500-2000 mg per day) 
due to its high solubility in water. 
The antioxidant properties of aqueous solutions formed by BDP and 
amines: meglumine and xymedon, were studied by in vitro 
experiment on rat blood. The antioxidant activity of glutathione 
reductase and catalase, activity of glucose-6-phosphate 
dehydrogenase were studied using data as percentage of control 
(table 5). The effect of BDP-amine complexes on enzyme activity was 
compared to the effect of individual components. 
 
Table 5: Biochemical indexes (catalase, glutathione reductase and glucose-6-phosphate dehydrogenase activities) of BDP-Megl and BDP-
Xym mixtures in phosphate buffer (pH 6.86). Molar ratio of BDP: amine is 1:4 
Compound Dose of BDP, µg·ml-1 Dose of amine, µg·ml-1 Index, % of control-1 
Catalase GR G6PD 
BDP 2.0 - 159±14 215±3 132±3 
5.0 - 172±9 179±3 167±4 
10.0 - 153±7 193±2 137±2 
Megl - 2.6 114±4 112±3 113±2 
- 6.5 112±8 143±3 99±3 
- 13.0 91±3 115±2 110±1 
BDP+Megl 2.0 2.6 170±3 239±3 151±3 
5.0 6.5 237±5 204±4 188±5 
10.0 13.0 197±9 225±2 198±3 
Xym - 2.2 134±3 133±2 134±1 
- 5.6 152±5 143±3 99±4 
- 11.2 191±2 185±5 110±2 
BDP+Xym 2.0 2.2 195±5 239±4 151±3 
5.0 5.6 187±6 204±8 188±3 
10.0 11.2 157±8 195±3 159±5 
1Number of replication of experiments was equal to 3. Biochemical indexes values are taken as 100%; catalase—31.35 Ru/mg protein; glutathione 
reductase — 91.29 nmol nicotinamide adenine dinucleotide phosphate (NADH)/min/mg protein, glucose-6-phosphate dehydrogenase—52.37 nmol 
NADPH/min/mg protein. 
 
Table 5 data show that the BDP-amine complexes formation 
promoted the significant increase in catalytic activity of catalase, 
glutathione reductase and glucose-6-phosphate dehydrogenase 
compared to the control. 
CONCLUSION 
Thus, we firstly obtained the aqueous solution of betulin-3,28-
diphosphate as a potential antioxidant pharmaceutical active 
ingredient at BDP concentration up to 59 g·l-1 in the presence of 
meglumine. This fact is very important to prepare injectable and 
other hydrophilic formulations because a poorly water-soluble 
BDP loses its initial solubility during aging and storage by 
transition of structural modifications. On the other hand, the poor 
water-soluble salt complex of BDP with extremely water-soluble 
xymedon (up to 300 g·l-1) can be used as an effective antioxidant-
regenerant with an optimal dose. 
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BDP interaction with amine (xymedon and meglumine) in an 
aqueous solution was shown to proceed via proton transfer due to 
relatively weak forces such as London forces, hydrogen bonding, 
electrostatic and hydrophobic interactions. In general, the formation 
of salt complexes of BDP with amines in solution determines BDP 
water solubility. 
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